• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫移植后每例活产的成本:瑞典活体供体试验的结果

The costs per live birth after uterus transplantation: results of the Swedish live donor trial.

作者信息

Brännström Mats, Ekberg Jana, Sandman Lars, Davidson Thomas

机构信息

Department of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.

Stockholm IVF-EUGIN, Stockholm, Sweden.

出版信息

Hum Reprod. 2025 Feb 1;40(2):310-318. doi: 10.1093/humrep/deae272.

DOI:10.1093/humrep/deae272
PMID:39675045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11788207/
Abstract

STUDY QUESTION

What is the cost per live birth after live donor uterus transplantation in a Swedish clinical trial setting?

SUMMARY ANSWER

The total cost per child, from a health care perspective, was calculated to be €124 894 and if only surgically successful transplants are considered, the total cost per live birth was €107 120.

WHAT IS KNOWN ALREADY

Uterus transplantation has proved to be a feasible treatment for uterine factor infertility by accomplished live births, both after live donor and deceased donor transplantation procedures. Our previous study, the only existing cost analysis of uterus transplantation, found that the initial (up to 2 months after surgeries) societal costs of preoperative interventions, live donor uterus transplantation surgeries, and postoperative care were between €50 000 and €100 000 (mean €74 000) in Year 2020 values per uterus transplantation. That study also included costs of sick leave for both donors and recipients.

STUDY DESIGN, SIZE, DURATION: This real-data health economic cost study is based on a prospective cohort study, which included nine live donor uterus transplantation procedures. Study duration included the time from the first pre-transplantation investigation until postoperative controls after graft removal.

PARTICIPANTS/MATERIALS, SETTING, METHODS: Recipients, live donors, and neonates of nine uterus transplantation procedures participated. The recipients and donors underwent pre-transplantation investigations with imaging, laboratory tests, and psychological/medical screening. In vitro fertilization with embryo cryopreservation was performed in advance of transplantation. Donor hysterectomy and transplantation were by laparotomy and the recipient received immunosuppression. Pregnancy attempts by ET started 1 year after transplantation and delivery was by caesarean section. Hysterectomy was performed either after birth of one or two children, after graft failure, or after multiple pregnancy failures. Nine transplantation procedures resulted in seven surgically successful (adequate blood flow and regular menstruations) grafts and six women delivered a total of nine children.

MAIN RESULTS AND THE ROLE OF CHANCE

The total cost of preoperative investigations, live donor uterus transplantation, postoperative care, immunosuppression, IVF, follow-up, pregnancy care, delivery, and graft removal after completed childbirth(s) or failure to achieve live birth was calculated, based on inclusion of cost for six women, giving birth to a total of nine children, and three women, with no childbirth. Cost for live donors was also included in the analysis. The total cost per child was calculated to be €124 894. However, if only surgical successful transplants (seven out of nine transplants) are considered, the cost per live birth was €107 120. The cost for preoperative preparations with IVF, surgeries, and postoperative follow-up during the initial 2 months was around 53% of total costs. Smaller sub-costs were those for monitoring, ETs with additional IVF (14%), immunosuppression and other drugs from Month 3 until hysterectomy (13%), and pregnancy care with delivery and neonatal care (13%).

LIMITATIONS, REASONS FOR CAUTION: Limitations are the restricted sample size, the experimental phase of the procedure and that the results only reflect the cost in one country (Sweden).

WIDER IMPLICATIONS OF THE FINDINGS

The results provide the first information concerning the cost per child of the uterus transplantation intervention. In the future, the cost per child will most likely decrease due to predicted increase in the rate of surgical success, decreased surgical durations, decreased graft duration to achieve live birth(s), and increased rate of transplantations giving not only one, but two or three singletons.

STUDY FUNDING/COMPETING INTEREST(S): Funding was received from the Jane and Dan Olsson Foundation for Science, the Knut and Alice Wallenberg Foundation, the Swedish Research Council, and an ALF grant from the Swedish state under an agreement between the government and the county councils. There are no conflicts of interest for any of the authors.

TRIAL REGISTRATION NUMBER

NCT01844362.

摘要

研究问题

在瑞典的临床试验环境中,活体供体子宫移植后每例活产的成本是多少?

总结答案

从医疗保健角度计算,每个孩子的总成本为124,894欧元;如果仅考虑手术成功的移植,每例活产的总成本为107,120欧元。

已知信息

子宫移植已被证明是一种治疗子宫因素不孕症的可行方法,通过活体供体和已故供体移植程序均已实现活产。我们之前的研究是子宫移植唯一现有的成本分析,发现2020年每例子宫移植术前干预、活体供体子宫移植手术和术后护理的初始(手术后头2个月)社会成本在50,000欧元至100,000欧元之间(平均74,000欧元)。该研究还包括供体和受体的病假成本。

研究设计、规模、持续时间:这项基于真实数据的卫生经济成本研究基于一项前瞻性队列研究,该研究包括9例活体供体子宫移植手术。研究持续时间包括从首次移植前调查到移植后移植物切除后的术后对照的时间。

参与者/材料、环境、方法:9例子宫移植手术的受体、活体供体和新生儿参与了研究。受体和供体接受了影像学、实验室检查以及心理/医学筛查等移植前调查。在移植前进行了胚胎冷冻保存的体外受精。供体子宫切除术和移植通过剖腹手术进行,受体接受免疫抑制治疗。移植后1年开始通过胚胎移植尝试怀孕,分娩通过剖宫产进行。在生育一两个孩子后、移植物失败后或多次怀孕失败后进行子宫切除术。9例移植手术中有7例手术成功(血流充足且月经规律)的移植物,6名女性共分娩了9个孩子。

主要结果及偶然性的作用

计算了术前检查、活体供体子宫移植、术后护理、免疫抑制、体外受精、随访、孕期护理、分娩以及分娩完成或未实现活产后移植物切除的总成本,纳入了6名生育了9个孩子的女性和3名未生育女性的成本,分析中还包括了活体供体的成本。计算得出每个孩子的总成本为124,894欧元。然而,如果仅考虑手术成功的移植(9例移植中的7例),每例活产的成本为107,120欧元。最初2个月内体外受精、手术及术后随访的术前准备成本约占总成本的53%。较小的子成本包括监测、额外体外受精的胚胎移植(14%)、第3个月至子宫切除期间的免疫抑制及其他药物(13%)以及孕期护理、分娩和新生儿护理(13%)。

局限性、需谨慎的原因:局限性在于样本量有限、该程序尚处于实验阶段且结果仅反映一个国家(瑞典)的成本。

研究结果的更广泛影响

该结果提供了关于子宫移植干预每个孩子成本的首个信息。未来,由于预计手术成功率提高、手术时间缩短、实现活产的移植物持续时间缩短以及不仅能生育一个,还能生育两个或三个单胎的移植率增加,每个孩子的成本很可能会降低。

研究资金/利益冲突:获得了简和丹·奥尔松科学基金会、克努特和爱丽丝·瓦伦贝里基金会、瑞典研究理事会的资助,以及瑞典政府与郡议会协议下瑞典国家提供的一项ALF资助。所有作者均无利益冲突。

试验注册号

NCT01844362

相似文献

1
The costs per live birth after uterus transplantation: results of the Swedish live donor trial.子宫移植后每例活产的成本:瑞典活体供体试验的结果
Hum Reprod. 2025 Feb 1;40(2):310-318. doi: 10.1093/humrep/deae272.
2
The costs of human uterus transplantation: a study based on the nine cases of the initial Swedish live donor trial.人类子宫移植的成本:基于最初的瑞典活体供者试验九例病例的研究。
Hum Reprod. 2021 Jan 25;36(2):358-366. doi: 10.1093/humrep/deaa301.
3
Long-term health-related quality-of-life and psychosocial outcomes after uterus transplantation: a 5-year follow-up of donors and recipients.子宫移植后长期的健康相关生活质量和心理社会结局:供体和受者 5 年随访。
Hum Reprod. 2024 Feb 1;39(2):374-381. doi: 10.1093/humrep/dead245.
4
Striving for motherhood after uterus transplantation: a qualitative study concerning pregnancy attempts, and the first years of parenthood after transplantation.子宫移植后对为人母的追求:一项关于妊娠尝试以及移植后为人父母最初几年的定性研究。
Hum Reprod. 2022 Jan 28;37(2):274-283. doi: 10.1093/humrep/deab260.
5
Donors' health-related quality-of-life and psychosocial outcomes 3 years after uterus donation for transplantation.供者子宫移植 3 年后的健康相关生活质量和心理社会结局。
Hum Reprod. 2019 Jul 8;34(7):1270-1277. doi: 10.1093/humrep/dez087.
6
Uterus transplantation: joys and frustrations of becoming a 'complete' woman-a qualitative study regarding self-image in the 5-year period after transplantation.子宫移植:成为“完整”女人的喜悦与挫折——移植后 5 年期间自我形象的定性研究。
Hum Reprod. 2020 Aug 1;35(8):1855-1863. doi: 10.1093/humrep/deaa143.
7
One uterus bridging three generations: first live birth after mother-to-daughter uterus transplantation.一个子宫连接三代人:母女子宫移植后的首例活产
Fertil Steril. 2016 Aug;106(2):261-6. doi: 10.1016/j.fertnstert.2016.04.001. Epub 2016 Apr 25.
8
Preclinical report on allogeneic uterus transplantation in non-human primates.非人类灵长类动物同种异体子宫移植的临床前报告。
Hum Reprod. 2013 Jan;28(1):189-98. doi: 10.1093/humrep/des381. Epub 2012 Oct 28.
9
Cost-effectiveness analysis of lifestyle intervention in obese infertile women.生活方式干预对肥胖不孕妇女的成本效益分析。
Hum Reprod. 2017 Jul 1;32(7):1418-1426. doi: 10.1093/humrep/dex092.
10
Global results of human uterus transplantation and strategies for pre-transplantation screening of donors.人类子宫移植的全球结果和供体移植前筛选策略。
Fertil Steril. 2019 Jul;112(1):3-10. doi: 10.1016/j.fertnstert.2019.05.030.

本文引用的文献

1
Long-term Course of Kidney Function in Uterus Transplant Recipients Under Treatment With Tacrolimus and After Transplantectomy: Results of the First Clinical Cohort.接受他克莫司治疗及移植肾切除术后子宫移植受者的肾功能长期病程:首个临床队列研究结果
Transplant Direct. 2023 Sep 28;9(10):e1525. doi: 10.1097/TXD.0000000000001525. eCollection 2023 Oct.
2
Uterus transplantation: from research, through human trials and into the future.子宫移植:从研究到临床试验再到未来。
Hum Reprod Update. 2023 Sep 5;29(5):521-544. doi: 10.1093/humupd/dmad012.
3
Commercial Surrogacy: An Overview.
商业代孕:概述。
Rev Bras Ginecol Obstet. 2022 Dec;44(12):1141-1158. doi: 10.1055/s-0042-1759774. Epub 2022 Dec 29.
4
Registry of the International Society of Uterus Transplantation: First Report.国际子宫移植协会登记处:首次报告。
Transplantation. 2023 Jan 1;107(1):10-17. doi: 10.1097/TP.0000000000004286. Epub 2022 Aug 11.
5
Reproductive, obstetric, and long-term health outcome after uterus transplantation: results of the first clinical trial.子宫移植后的生殖、产科和长期健康结局:首次临床试验结果。
Fertil Steril. 2022 Sep;118(3):576-585. doi: 10.1016/j.fertnstert.2022.05.017. Epub 2022 Jun 11.
6
Birth of a Healthy Baby 9 Years After a Surgically Successful Deceased Donor Uterus Transplant.一名健康婴儿的诞生:一名接受过成功的已故供体子宫移植手术的患者 9 年后。
Ann Surg. 2022 May 1;275(5):825-832. doi: 10.1097/SLA.0000000000005346. Epub 2021 Dec 16.
7
The Future of Uterus Transplantation: Cost, Regulations, and Outcomes.子宫移植的未来:成本、监管与结果。
Clin Obstet Gynecol. 2022 Mar 1;65(1):101-107. doi: 10.1097/GRF.0000000000000685.
8
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.《2022 年健康经济评估报告标准》(CHEERS 2022)声明:更新的健康经济评估报告指南。
BMJ. 2022 Jan 11;376:e067975. doi: 10.1136/bmj-2021-067975.
9
Hysterectomy after uterus transplantation and detailed analyses of graft failures.子宫移植后子宫切除术和移植物失败的详细分析。
Acta Obstet Gynecol Scand. 2022 Mar;101(3):355-363. doi: 10.1111/aogs.14304. Epub 2021 Dec 14.
10
Imaging evaluation of uterine arteries in potential living donors for uterus transplantation: a comparative study of MRA, CTA, and DSA.子宫移植潜在供体子宫动脉的影像学评估:MRA、CTA 和 DSA 的对比研究。
Eur Radiol. 2022 Apr;32(4):2360-2371. doi: 10.1007/s00330-021-08350-6. Epub 2021 Nov 12.